CVS Health plans split between pharmacy and insurance businesses
CVS Health plans to split into separate pharmacy and insurance businesses, according to Investing.com. The separation would divide a company that generated $402.1 billion in fiscal 2025 revenue across two distinct operating models.
STOCK PHOTO · LEE STARRYThe story
The planned transaction would separate CVS Health’s pharmacy business from its insurance operations, creating two standalone companies. Investing.com reported the decision on Nov. 4, 2026, but the terms, structure and timetable were not specified.
CVS’s fiscal 2025 results provide the latest company-level scale: revenue was $402.1 billion, up 7.8% year over year, while net margin was 0.4% and diluted EPS was $1.39. The proposed split would therefore reorganize a large, low-margin enterprise rather than add a new business line.
The pharmacy business and insurance operations would have different revenue sources, costs and regulatory exposures once separated. Pharmacy activity is tied to dispensing and retail operations, while insurance depends on premiums, medical costs and government-program economics; the reporting establishes the intended separation but not how assets, liabilities or management would be allocated.
Key open points are the transaction structure, tax treatment, debt allocation, leadership, regulatory approvals and timing. Those details would determine how much of CVS’s existing scale and cost base each company retains.
Our read · Wed, Nov 4
CVS Health plans to separate its pharmacy business from its insurance operations.
Why. The split could make CVS’s pharmacy and insurance economics easier to assess, but the trade setup depends on details that determine where the company’s debt, costs and regulatory obligations land. CVS’s fiscal 2025 profile—$402.1 billion of revenue, 0.4% net margin and $1.39 diluted EPS—leaves substantial execution and allocation questions for the separation to resolve.
Both cases
What could change this view: The read fails if the separation is delayed, regulatory or tax costs rise, or debt and overhead allocations leave either standalone business with weaker economics.
Who reported it · 4
Keep reading
More on CVS
CVS warns medical-cost growth remains at high trend; UnitedHealth, Oscar shares fallHealth insurers withdrawing Medicare Advantage plans, affecting seniors in rural marketsLatest on the Wire
AMD shares fall 11% after Hunterbrook warns over China linksWalmart raises full-year outlook as e-commerce wins shoppersAnthropic IPO could become the largest in US history on ThursdayContinuing claims rise as Goldman sees Fed hikes in December and MarchPIF Tower in Riyadh reportedly damaged in second Houthi attackContinue on the Wire →Latest on the Wire
Biohaven reports confirmed BHV-1530 responses in two FGFR3 cancersTrump, Xi and Putin pledge more refined fuel after first trilateral summitSky reserve linked to $518 million in illicit activity, investigation findsBitcoin nears $64,000 as Anthropic IPO lifts Nasdaq futures nearly 2%Continue on the Wire →Top this week
Nvidia allies lobby board to bring back Jensen Huang as CEONvidia chair rules out Huang return as CEO after 75% sales outlookAnthropic Said to Guide IPO Pricing Above Market RangeNvidia interim CEO Colette Kress faces first earnings test after HuangNvidia CEO Jensen Huang reportedly resigns as US-China tensions riseAbout this report
Reported by Investing.com as CVS Health to split in two, separating pharmacy business from insurance
, . Who answers for this
4 reports from 4 publishers in this record. Closes are licensed end-of-day data from Databento; the move after a story is its first close against the close before it. How this is decided →
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →
